Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) — Market Cap & Net Worth
Market Cap & Net Worth: Torrent Pharmaceuticals Limited (TORNTPHARM)
Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) has a market capitalization of $16.49 Billion (Rs1.52 Trillion) as of June 16, 2026. Listed on the NSE stock exchange, this India-based company holds position #1532 globally and #49 in its home market, demonstrating a 1.88% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Torrent Pharmaceuticals Limited's stock price Rs4504.00 by its total outstanding shares 338445440 (338.45 Million). Review Torrent Pharmaceuticals Limited debt and liabilities to assess the company's total debt and financial obligations.
Torrent Pharmaceuticals Limited Market Cap History: 2015 to 2026
Torrent Pharmaceuticals Limited's market capitalization history from 2015 to 2026. Data shows growth from $2.37 Billion to $16.49 Billion (19.38% CAGR).
Index Memberships
Torrent Pharmaceuticals Limited is a constituent of 8 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY PHARMA
CNXPHARMA
|
$92.14 Billion | 17.89% | #1 of 20 |
|
NIFTY 100
NIFTY100
|
$2.00 Trillion | 0.82% | #42 of 100 |
|
NIFTY100 EQUAL WEIGHT
NIFTY100EW
|
$1.75 Trillion | 0.94% | #34 of 99 |
|
NIFTY 200
NIFTY200
|
$2.53 Trillion | 0.65% | #45 of 200 |
|
NIFTY 500
NIFTY500
|
$3.10 Trillion | 0.53% | #46 of 500 |
|
NIFTY HEALTHCARE
NIFTYHEALTHCARE
|
$110.61 Billion | 14.90% | #1 of 20 |
|
Nifty Low Volatility 50
NIFTYLVI
|
$949.49 Billion | 1.74% | #17 of 48 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.18 Trillion | 0.52% | #45 of 750 |
Weight: Torrent Pharmaceuticals Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Torrent Pharmaceuticals Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Torrent Pharmaceuticals Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.12x
Torrent Pharmaceuticals Limited's market cap is 0.12 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.76x
Torrent Pharmaceuticals Limited's market cap is 0.76 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $2.41 Billion | $56.72 Billion | $9.34 Billion | 0.04x | 0.26x |
| 2018 | $3.03 Billion | $58.25 Billion | $6.78 Billion | 0.05x | 0.45x |
| 2019 | $3.20 Billion | $74.62 Billion | $4.36 Billion | 0.04x | 0.73x |
| 2020 | $4.88 Billion | $77.80 Billion | $10.25 Billion | 0.06x | 0.48x |
| 2021 | $5.79 Billion | $78.86 Billion | $12.52 Billion | 0.07x | 0.46x |
| 2022 | $5.54 Billion | $84.19 Billion | $7.77 Billion | 0.07x | 0.71x |
| 2023 | $8.35 Billion | $94.64 Billion | $12.45 Billion | 0.09x | 0.67x |
| 2024 | $12.30 Billion | $105.62 Billion | $16.56 Billion | 0.12x | 0.74x |
| 2025 | $14.09 Billion | $113.17 Billion | $19.11 Billion | 0.12x | 0.74x |
| 2026 | $16.49 Billion | $139.80 Billion | $21.63 Billion | 0.12x | 0.76x |
Competitor Companies of TORNTPHARM by Market Capitalization
Companies near Torrent Pharmaceuticals Limited in the global market cap rankings as of June 16, 2026.
Key companies related to Torrent Pharmaceuticals Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #512 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #560 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #613 globally with a market cap of $44.69 Billion USD ( CN¥305.43 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #629 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #512 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #560 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.41 |
| #613 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $44.69 Billion | CN¥47.88 |
| #629 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.60 |
Torrent Pharmaceuticals Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Torrent Pharmaceuticals Limited's market cap moved from $2.37 Billion to $ 16.49 Billion, with a yearly change of 19.38%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs16.49 Billion | +16.99% |
| 2025 | Rs14.09 Billion | +14.58% |
| 2024 | Rs12.30 Billion | +47.26% |
| 2023 | Rs8.35 Billion | +50.70% |
| 2022 | Rs5.54 Billion | -4.24% |
| 2021 | Rs5.79 Billion | +18.50% |
| 2020 | Rs4.88 Billion | +52.73% |
| 2019 | Rs3.20 Billion | +5.41% |
| 2018 | Rs3.03 Billion | +26.09% |
| 2017 | Rs2.41 Billion | +8.92% |
| 2016 | Rs2.21 Billion | -6.77% |
| 2015 | Rs2.37 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of Torrent Pharmaceuticals Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $16.49 Billion USD |
| MoneyControl | $16.49 Billion USD |
| MarketWatch | $16.49 Billion USD |
| marketcap.company | $16.49 Billion USD |
| Reuters | $16.49 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, CNS, urology, gynecology, oncology, gastro-int… Read more